Inflammation-based prognostic score is a useful predictor of postoperative outcome in patients with extrahepatic cholangiocarcinoma
Background/purpose Recent studies have revealed that the Glasgow prognostic score (GPS), an inflammation-based prognostic score, is useful for predicting outcome in a variety of cancers. This study sought to investigate the significance of GPS for prognostication of patients who underwent surgery wi...
Saved in:
Published in | Journal of hepato-biliary-pancreatic sciences Vol. 20; no. 3; pp. 389 - 395 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Japan
Blackwell Publishing Ltd
01.03.2013
Springer Japan Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Background/purpose
Recent studies have revealed that the Glasgow prognostic score (GPS), an inflammation-based prognostic score, is useful for predicting outcome in a variety of cancers. This study sought to investigate the significance of GPS for prognostication of patients who underwent surgery with extrahepatic cholangiocarcinoma.
Methods
We retrospectively analyzed a total of 62 patients who underwent resection for extrahepatic cholangiocarcinoma. We calculated the GPS as follows: patients with both an elevated C-reactive protein (>10 mg/L) and hypoalbuminemia (<35 g/L) were allocated a score of 2; patients with one or none of these abnormalities were allocated a score of 1 or 0, respectively. Prognostic significance was analyzed by the log-rank test and a Cox proportional hazards model.
Results
Overall survival rate was 25.5 % at 5 years for all 62 patients. Venous invasion (
p
= 0.01), pathological primary tumor category (
p
= 0.013), lymph node metastasis category (
p
< 0.001), TNM stage (
p
< 0.001), and GPS (
p
= 0.008) were significantly associated with survival by univariate analysis. A Cox model demonstrated that increased GPS was an independent predictive factor with poor prognosis.
Conclusions
The preoperative GPS is a useful predictor of postoperative outcome in patients with extrahepatic cholangiocarcinoma. |
---|---|
Bibliography: | ArticleID:JHBP2017 ark:/67375/WNG-9XW8Z5KB-D istex:19260ABB33504D083F31C5F4DF41E84DE7C48243 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1868-6974 1868-6982 |
DOI: | 10.1007/s00534-012-0550-6 |